Dr. Jessica Shanshan Maslin, MD

Dr. Maslin practices at Eye Institute of California Medical Group Inc in Chula Vista, California.

Dr. Maslin's NPI, 1154684553, was assigned on June 20, 2012. Dr. Maslin graduated from UC San Diego School of Medicine in 2012. Dr. Maslin holds California license A140884.

Dr. Maslin's primary practice is Eye Institute of California Medical Group Inc, at 480 4th Ave, Chula Vista, CA 91910 in San Diego County. The practice phone is (619) 427-3355.

Dr. Maslin's primary practice is Eye Institute of California Medical Group Inc in Chula Vista, California. Dr. Maslin is also affiliated with Scripps Mercy Hospital San Diego. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Maslin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maslin practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Maslin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Maslin is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Maslin is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Maslin treats.

CMS data shows 2,161 Medicare services from Dr. Maslin across 16 procedure codes in 2024, for 757 Medicare patients. Medicare paid $179,515 for them.

CMS counts 757 Medicare patients who saw Dr. Maslin in 2024. The largest group is 65 to 74, with 290 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maslin's median patient age at 76, with 56% women.

In 2024, Dr. Maslin wrote 5,179 Medicare Part D claims for 973 patients. 56% of them were for generic drugs. CMS names the drug for 5,094 of them, across 27 drugs with 11 or more claims each, at $617,364 in total drug cost. In 2023, CMS named 4,331 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Maslin for performance year 2024, reported as part of a group. Dr. Maslin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 120 procedures of cataract surgery by Dr. Maslin, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Maslin, published from 2015 to 2020. 2016 was the busiest year, with 5. The most frequent topics are Intraocular Pressure, Ciliary Body and Glaucoma. Dr. Maslin has published most often in Clin Ophthalmol. Dr. Maslin's most frequent co-authors are Nisha Chadha, MD, Ji Liu, MD and Robert John Noecker, MD.

CMS Open Payments shows 184 general payments to Dr. Maslin from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Glaukos Corporation paid the most, $1,772.

Dmand AI lists 4 awards for Dr. Maslin, most recently San Diego Top Doctors - Physicians of Exceptional Excellence in 2023.

Dr. Maslin graduated from UC San Diego School of Medicine in 2012. Dr. Maslin is a member of AAO, American Glaucoma Society and American Society of Cataract and Refractive Surgeons.

Dr. Maslin is in network with 12 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.